This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Zahn, E. M. Articles by McElhinney, D. B. PubMed Articles by Zahn, E. M. Articles by McElhinney, D. B. Related Collections Related Article

INTERVENTIONAL CARDIOLOGY

Implantation of the Melody Transcatheter Pulmonary Valve in Patients With a Dysfunctional Right Ventricular Outflow Tract Conduit

Early Results From the U.S. Clinical Trial

Evan M. Zahn, MD^_*, William E. Hellenbrand, MD, James E. Lock, MD and Doff B. McElhinney, MD^,_*

^_* Division of Cardiology, Miami Children's Hospital, Miami, Florida
Division of Cardiology, Morgan Stanley Children's Hospital, New York, New York
Department of Cardiology, Children's Hospital Boston, Boston, Massachusetts

Manuscript received March 17, 2009; revised manuscript received June 16, 2009, accepted June 22, 2009.

^_* Reprint requests and correspondence: Dr. Doff B. McElhinney, Department of Cardiology, Children's Hospital, 300 Longwood Avenue, Boston, Massachusetts 02115 (Email: doff.mcelhinney{at}cardio.chboston.org).

Objectives: This study was designed to evaluate the safety, procedural success, and short-term effectiveness of the Melody transcatheter pulmonary valve (Medtronic, Inc., Minneapolis, Minnesota) in patients with dysfunctional right ventricular outflow tract conduits.

Background: Conduit dysfunction has recently been treated with transcatheter pulmonary valve placement. There have been no prospective, multicenter trials evaluating this technology.

Methods: Standardized entry criteria, implantation, and follow-up protocols were used. Nonimplanting core laboratories were used to evaluate results.

Results: Between January 2007 and September 2007, 34 patients underwent catheterization for intended Melody valve implantation at 3 centers. Mean age was 19.4 ± 7.7 years. Initial conduit Doppler mean gradient was 28.8 ± 10.1 mm Hg, and 94% of patients had moderate or severe pulmonary regurgitation (PR). Implantation was successful in 29 of 30 attempts and not attempted in 4 patients. Procedural complications included conduit rupture requiring urgent surgery and device removal (n = 1), wide-complex tachycardia (n = 1), and distal pulmonary artery guidewire perforation (n = 1). Peak systolic conduit gradient fell acutely from 37.2 ± 16.3 mm Hg to 17.3 ± 7.3 mm Hg, and no patient had more than mild PR. There were no deaths or further device explants. At 6-month follow-up, conduit Doppler mean gradient was 22.4 ± 8.1 mm Hg, and PR fraction by magnetic resonance imaging was significantly improved (3.3 ± 3.6% vs. 27.6 ± 13.3%, p < 0.0001). Stent fracture occurred in 8 of 29 implants; 3 of these were treated with a second Melody valve for recurrent stenosis later in follow-up.

Conclusions: Implantation of the Melody valve for right ventricular outflow tract conduit dysfunction can be performed by experienced operators at multiple centers, appears safe, and has encouraging acute and short-term outcomes.

Key Words: intervention • pulmonary valve • tetralogy of Fallot

Abbreviations and Acronyms   cMRI = cardiac magnetic resonance imaging   CPET = cardiopulmonary exercise test/testing   CT = computed tomography   NYHA = New York Heart Association   PA = pulmonary artery   PR = pulmonary regurgitation   RV = right ventricle   RVOT = right ventricular outflow tract   VO2 = oxygen consumption

Related Article

Inside This Issue
J. Am. Coll. Cardiol. 2009 54: A26. [Full Text] [PDF]